Quick Answer
CollPlant Biotechnologies Ltd reported Cash And Cash Equivalents At Carrying Value of $5.59 million for the year ending 2025.
- CollPlant Biotechnologies Ltd showed a decrease of -53.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CollPlant Biotechnologies Ltd's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), CollPlant Biotechnologies Ltd's Cash And Cash Equivalents At Carrying Value has grown by 4.4%.
- Historical annual values: Fiscal year 2025: $5.59 million | Fiscal year 2024: $11.91 million | Fiscal year 2023: $26.67 million | Fiscal year 2022: $29.65 million | Fiscal year 2021: $13.15 million | Fiscal year 2020: $3.33 million | Fiscal year 2019: $3.79 million | Fiscal year 2018: $5.35 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: